Left atrial appendage closure device involves a procedure that reduces the risk of stroke in atrial fibrillation patients. It also reduces the risk of bleeding that comes with a long-term use of oral anticoagulants. The WATCHMAN Device is permanently implanted at the site or slightly distal to the ostium of the LAA (the source of more than 90% of stroke-causing bloods clots in atrial fibrillation patients).